Stanley Fineman, MD
Allergy & Immunology · Marietta, GANPI 1386684207
Payments from drug & device makers
Across 632 payments — averaging $1353.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aimmune Therapeutics, Inc.$373K
- Novartis$184K
- Regeneron$99K
- Sanofi$74K
- Biocryst Pharmaceuticals, Inc.$29K
- Shire North American Group Inc$25K
- plus $72K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aimmune Therapeutics, Inc. | 79 | $373,054 |
| Novartis | 45 | $183,716 |
| Regeneron | 17 | $98,659 |
| Sanofi | 30 | $73,558 |
| Biocryst Pharmaceuticals, Inc. | 14 | $29,019 |
| Shire North American Group Inc | 26 | $24,750 |
| Takeda Pharmaceuticals U.S.A., Inc. | 56 | $19,410 |
| Genentech USA, Inc. | 30 | $18,247 |
| Biocryst US Sales Co., LLC | 35 | $12,557 |
| Pharming Healthcare, Inc. | 12 | $7,185 |
| Teva Pharmaceuticals USA, Inc. | 17 | $5,360 |
| Alk-abello, Inc | 5 | $3,071 |
| CSL Behring | 55 | $1,362 |
| AstraZeneca | 36 | $1,084 |
| Optinose US, Inc. | 12 | $993 |
| Regeneron Healthcare Solutions, Inc. | 38 | $818 |
| GSK | 43 | $550 |
| Kaleo, Inc. | 18 | $337 |
| Covis Pharma GmbH | 13 | $261 |
| Pfizer | 13 | $248 |
| Grifols USA, LLC | 11 | $212 |
| Boehringer Ingelheim | 10 | $194 |
| Octapharma USA, Inc. | 3 | $177 |
| Amgen(2 entities) | 7 | $146 |
| Blueprint Medicines Corporation | 2 | $63 |
| Merck | 2 | $34 |
| AbbVie | 2 | $27 |
| ADMA Biomanufacturing LLC | 1 | $23 |
How this compares
$855,114 in reported general payments places this provider in the 95th percentile of 107 allergy & immunology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in Marietta
- Grace ChiangMarietta$5K
- Nathan SegallStockbridge$4.5M
- Tracy BridgesAlbany$1.5M
- Brad GoodmanSavannah$1.3M
- Michael BlaissRoswell$1.1M
- Robert ChrzanowskiColumbus$941K
- Robert CartwrightColumbus$678K
- Deborah BirxAtlanta$470K
- Jack EadesMacon$282K
- Bruce FinkelSavannah$277K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.